REGENXBIO Inc. (RGNX) slipped -16.41% or -5.78 to $29.43. It is approximately 1.39 million shares traded, which is 450.64% compare to the average total volume 309545. The market cap of RGNX is $916.45 million. The year to date change is 1.29%. The 52 week price range is from $16.3 to $36.45. Price of RGNX have changed 2.92% during last week. It have changed 26.62% over last month, 10.00% over last 3 months, 71.71% over last 6 months and 90.27% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RGNX is 29.62. It is 0.65% above current price. The stock faces resistance at 50-day moving averages. The 200-day Moving Averages for RGNX is 23.99. It is -18.48% below current price. The 52-week High is 36.45. It is 23.85% from the current price. The 52-week Low is 16.3. It is -44.61% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of RGNX is 4.03 on 2017-12-15. Short % to float is 4.30%. There are some statistics of RGNX. It is has market cap $916.45 million. The share outstanding is 31.15 million. The average volume is 309545. The percent of top 15 Institution holding is 61.40%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RGNX is -40.96%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RGNX is -37.89%.